Siyu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Siyu Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Chen Dong
Department of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Shijiazhuang, Hebei Province, China
1 shared publication - Huiming Jin
Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Henan, China
1 shared publication - Jia Shang
Department of Infectious Diseases, Henan Provincial People’s Hospital, Zhengzhou, Henan, China
1 shared publication - Lu Li
Department of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital & Hebei International Joint Research Center for Liver Cancer Molecular Diagnosis, Hebei International Science and Technology Cooperation Base, Shijiazhuang, Hebei Province, 050051, People’s Republic of China
1 shared publication - Mengmeng Hou
Department of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Shijiazhuang, Hebei Province, China
1 shared publication - Xiaoxiao Zhang
Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Shijiazhuang, Hebei, China
1 shared publication
Latest Publications
- Open Access
- 13 May 2022
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
The impact of nonalcoholic fatty liver disease (NAFLD) on the treatment outcome of chronic hepatitis B (CHB) is undefined and deserves an in-depth investigation.
- 13 May 2022
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Open AccessAdverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
The impact of nonalcoholic fatty liver disease (NAFLD) on the treatment outcome of chronic hepatitis B (CHB) is undefined and deserves an in-depth investigation.